The discovery of PCSK9 as a pivotal point in the prevention of cardiovascular disease
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is an important component in the regulation of low-density lipoprotein-cholesterol (LDL-C) metabolism, discovered more than two decades ago. The discovery of PCSK9 and subsequent development of PCSK9 inhibitors (PCSK9i) have helped usher a new er...
שמור ב:
| Principais autores: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2025-12-01
|
| סדרה: | American Journal of Preventive Cardiology |
| נושאים: | |
| גישה מקוונת: | http://www.sciencedirect.com/science/article/pii/S2666667725003897 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|